ESPR
Esperion Therapeutics Inc
NASDAQ: ESPR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.00
+4.71% today
Updated 2026-04-30
Market cap
$491.64M
P/E ratio
—
P/S ratio
1.22x
EPS (TTM)
$-0.11
Dividend yield
—
52W range
$1 – $4
Volume
6.1M
Esperion Therapeutics Inc (ESPR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 1999 | 2000 | 2001 | 2002 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-7.85M | $-17.95M | $-22.77M | $-26.56M | $-9.07M | $-10.81M | $-18.11M | $-32.02M | $-38.16M | $-47.73M | $-131.30M | $-148.64M | $-70.34M | $-85.18M | $-263.81M | $-174.83M | $-135.49M | $-23.65M | $-13.09M |
| Capital expenditures | $1.56M | $1.34M | $2.02M | $1.16M | $33635.00 | $6783.00 | $31373.00 | $873000.00 | $325000.00 | $94000.00 | $19000.00 | $151000.00 | $953000.00 | $13.37M | $0.00 | $0.00 | $0.00 | $317000.00 | $189000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | $78451.00 | $79861.00 | $1.23M | $3.68M | $12.73M | $15.96M | $18.61M | $23.97M | $25.88M | $28.39M | $24.31M | $15.21M | $11.96M | $11.99M | $9.87M |
| Free cash flow | $-9.42M | $-19.30M | $-24.79M | $-27.72M | $-9.10M | $-10.82M | $-18.14M | $-32.89M | $-38.48M | $-47.82M | $-131.32M | $-148.79M | $-71.29M | $-98.55M | $-263.81M | $-174.83M | $-135.49M | $-23.97M | $-13.28M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | $302.73M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | $50.03M | $28.50M | $-7.70M | $-39.17M | $-3.70M | $2.50M | $130.09M | $137.90M | $-46.07M | $-134.12M | — | — | — |